Skip to main content

Vertex Pharmaceuticals Inc.

VRTXHealthcare
CIK 0001449933SIC 3571Biotechnology
Market Cap

$124.7B

+2.4% today
Sector & Industry

Healthcare

Biotechnology

SEC Filings

517

Total filings on record

Last Filing

Jan 28, 2026

8-K — Board of Directors Update

Showing 15 filings
Form TypeFiled DateAcceptedDescriptionAccessionActions
10-QJan 28, 2026Jan 28, 2026Quarterly Report for period ended March 20250001449933-26-715409
DEF 14ADec 23, 2025Dec 23, 2025Definitive Proxy Statement for Annual Meeting0001449933-26-645396
S-1Nov 27, 2025Nov 27, 2025Registration Statement0001449933-26-299957
13FNov 3, 2025Nov 3, 2025Institutional Investment Manager Holdings Report0001449933-26-602049
Form 4Oct 10, 2025Oct 10, 2025Statement of Changes - Sarah Jones0001449933-26-270813
Form 4Sep 14, 2025Sep 14, 2025Statement of Changes - Linda Rodriguez0001449933-26-674572
Form 4Aug 16, 2025Aug 16, 2025Statement of Changes - Linda Rodriguez0001449933-26-699548
S-1Jul 20, 2025Jul 20, 2025Registration Statement0001449933-26-125438
S-1Jun 16, 2025Jun 16, 2025Registration Statement0001449933-26-320781
S-1May 22, 2025May 22, 2025Registration Statement0001449933-26-612091
S-1Apr 20, 2025Apr 20, 2025Registration Statement0001449933-25-638902
S-1Mar 22, 2025Mar 22, 2025Registration Statement0001449933-25-374152
DEF 14AFeb 20, 2025Feb 20, 2025Definitive Proxy Statement for Annual Meeting0001449933-25-885877
DEF 14AJan 26, 2025Jan 26, 2025Definitive Proxy Statement for Annual Meeting0001449933-25-674342
10-KDec 29, 2024Dec 29, 2024Annual Report for fiscal year ended December 20250001449933-25-773867